4-peptide and 12-peptide Melanoma Vaccines: 1 Clinical Trial

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Condition(s):MelanomaLast Updated:May 2, 2018Completed